---
title: "Wall Street's Oddball Bin: Real Cash, AI Posers, and Market Ghosts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298437880.md"
description: "This bizarre basket mixes profitable tech survivors with companies surviving purely on buzzwords. Ignore the hype and watch the free cash flow in 2026."
datetime: "2026-09-09T10:12:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298437880.md)
  - [en](https://longbridge.com/en/news/298437880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298437880.md)
generator: "portal-rs"
---

# Wall Street's Oddball Bin: Real Cash, AI Posers, and Market Ghosts

I’ve seen a lot of weird market groupings, but this basket is one of the most bizarre oddball bins on Wall Street. You’ve got tech survivors actually printing cash off edge computing and drug commercialization, thrown together with hollow shells surviving purely on buzzwords. It’s like a documentary of market survival in 2026. This is stupid and here's why.

Let’s start with the real businesses. **Fastly (FSLY.US)** is finally showing some teeth. They posted a record USD 183.3M in Q2 2026 revenue. The edge cloud and AI infrastructure demand is real, and they are capitalizing on it despite executive stock sales. The same goes for **JFrog (FROG.US)**, which saw its cloud business skyrocket 53% in the same quarter, bagging more massive enterprise clients. DevOps isn’t sexy, but it’s insanely lucrative. Why aren't other software firms moving this fast?

In biotech, **Liquidia (LQDA.US)** pulled off a massive turnaround. From heavy losses to pulling in USD 170M in Q2 2026 revenue with net income hitting USD 74.7M, driven by their YUTREPIA launch. This is what happens when a product actually works. Meanwhile, the ultimate boring business, **Kimberly-Clark (KMB.US)**, quietly raked in USD 4.2B in quarterly sales by relentlessly cutting costs and selling toilet paper. In a market obsessed with generative AI, this level of predictability is rare.

But then we have the absolute head-scratchers. **Evolv Technologies (EVLV.US)** grew its AI security screening revenue by 34% this quarter, yet its stock has been scraping the bottom of its recent range. Wall Street is clearly losing patience with its lack of profitability. And if you want a masterclass in trend-chasing, look at **The OLB Group (OLB.US)**. Their quarterly revenues shrank to a mere USD 1.28M, so they pivoted to Bitcoin mining, and now they are pivoting again to AI-assisted software. This is a walking buzzword bingo card. Good luck with that. Then there is the **United States Commodity Index Fund (USDE.US)**, which is just a straightforward ETF vehicle for commodity futures.

The worst part of this group? The absolute ghosts. **Kensington Capital Acquisition Corp. V (KMEM.US)** is the rotting corpse of the SPAC boom that liquidated earlier, proving the dead-end nature of blank check companies. **Pendrell (PCLA.US)** is an IP shell with virtually no pulse, and **BTCI (BTCI.US)** doesn’t even have basic recent market data available. Are they even trying? Do not waste your time on these illiquid zombies.

*This article does not constitute investment advice.*

### Related Stocks

- [FSLY.US](https://longbridge.com/en/quote/FSLY.US.md)
- [LQDA.US](https://longbridge.com/en/quote/LQDA.US.md)
- [PCLA.US](https://longbridge.com/en/quote/PCLA.US.md)
- [FROG.US](https://longbridge.com/en/quote/FROG.US.md)
- [EVLV.US](https://longbridge.com/en/quote/EVLV.US.md)
- [KMB.US](https://longbridge.com/en/quote/KMB.US.md)
- [USDE.US](https://longbridge.com/en/quote/USDE.US.md)
- [OLB.US](https://longbridge.com/en/quote/OLB.US.md)

## Related News & Research

- [Here’s How Much You Would Have Made Owning JFrog Stock In The Last 5 Years](https://longbridge.com/en/news/300455836.md)
- [Should Patent Remedy Risk Require Action From Liquidia (LQDA) Investors?](https://longbridge.com/en/news/300896606.md)
- [Fastly CTO Artur Bergman disposes of USD 916,999 in common shares](https://longbridge.com/en/news/300621105.md)
- [Fastly consensus price target increased by 12.31% to MX$521.75](https://longbridge.com/en/news/300764990.md)
- [Liquidia: Court finds two claims of ’327 patent valid and infringed, parties to propose remedies](https://longbridge.com/en/news/300621915.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**